TNF Pharmaceuticals Goodwill and Intangible Assets 2012-2025 | TNFA

TNF Pharmaceuticals goodwill and intangible assets from 2012 to 2025. Goodwill and intangible assets can be defined as the sum of all intangible asset fields

TNF Pharmaceuticals Goodwill and Intangible Assets 2012-2025 | TNFA

TNF Pharmaceuticals goodwill and intangible assets from 2012 to 2025. Goodwill and intangible assets can be defined as the sum of all intangible asset fields
Related Stocks
Company NameMarket
Cap
Chugai Pharmaceutical (CHGCY)$76.5B
Zoetis (ZTS)$69.3B
Takeda Pharmaceutical (TAK)$47.9B
Daiichi Sankyo, - (DSNKY)$42.7B
BeOne Medicines - (ONC)$27.6B
Sandoz Group AG (SDZNY)$24.9B
Summit Therapeutics (SMMT)$18.9B
Merck (MKKGY)$16.7B
Shionogi (SGIOY)$14.2B
United Therapeutics (UTHR)$13.4B
Neurocrine Biosciences (NBIX)$13.4B
Orion OYJ (ORINY)$11B
IPSEN (IPSEY)$10.3B
Stevanato Group S.p.A (STVN)$7.8B
Corcept Therapeutics (CORT)$7.7B
Madrigal Pharmaceuticals (MDGL)$7.1B
Ionis Pharmaceuticals (IONS)$6.8B
Grifols, S.A (GRFS)$6.7B
Hikma Pharmaceuticals Plc (HKMPF)$6.2B
Ono Pharmaceutical (OPHLF)$5.3B
Soleno Therapeutics (SLNO)$4.2B
Crinetics Pharmaceuticals (CRNX)$3.1B
Hypermarcas (HYPMY)$3B
AMNEAL PHARMACEUTICALS, INC (AMRX)$2.6B
Catalyst Pharmaceuticals (CPRX)$2.6B
NewAmsterdam Pharma (NAMS)$2.5B
Centessa Pharmaceuticals (CNTA)$2B
BioCryst Pharmaceuticals (BCRX)$1.9B
Ocular Therapeutix (OCUL)$1.8B
ARS Pharmaceuticals (SPRY)$1.8B